Press Releases about Cyteir Therapeutics Inc
![](https://mms.businesswire.com/media/20240307328830/en/2057884/5/cyteir-logo-vertical-1000px.jpg)
From Cyteir Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20231012887827/en/1913713/5/cyteir-logo-vertical-1000px.jpg)
![](https://spotlightgrowth.com/wp-content/uploads/2023/06/Cyteir-Therapeutics-Dissolution-NASDAQ-CYT-Business-Shut-Down-Spotlight-Growth.jpg)
![](https://mms.businesswire.com/media/20230630372398/en/1832514/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20230603005002/en/1809342/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20230510005920/en/1790040/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20230323005237/en/1745545/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20230206005229/en/1705488/5/cyteir-logo-vertical-1000px.jpg)
Cyteir Therapeutics Promotes David Gaiero to Chief Financial Officer
February 06, 2023
From Cyteir Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20230119005876/en/1691206/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20221107006035/en/1628182/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20221012005227/en/1598934/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220831005133/en/1557336/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220808005765/en/1538279/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220801005239/en/1530048/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220605005073/en/1476693/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220531005297/en/1470694/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220505006093/en/1445689/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220504005174/en/1442060/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220503005579/en/1440915/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220425005305/en/1430578/5/cyteir-logo-vertical-1000px.jpg)
Cyteir Therapeutics Names Adam Veness General Counsel
April 25, 2022
From Cyteir Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20220418005211/en/1423000/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220316005741/en/1392151/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220224006071/en/1371493/5/cyteir-logo-vertical-1000px.jpg)
Cyteir Therapeutics Announces the Appointment of Stephen Sands to Board of Directors
February 24, 2022
From Cyteir Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20220208005264/en/1351646/5/cyteir-logo-vertical-1000px.jpg)
From Cyteir Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20220207005278/en/1350667/5/cyteir-logo-vertical-1000px.jpg)
Cyteir Therapeutics Announces the Appointment of John F. Thero to Board of Directors
February 07, 2022
From Cyteir Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20220112005369/en/1325805/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20220103005085/en/1316532/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20211216005234/en/1308319/5/cyteir-logo-vertical-1000px.jpg)
![](https://mms.businesswire.com/media/20211112005494/en/926458/5/cyteir-logo-vertical-1000px.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.